Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-123-ADAM SPECT for SERT Availability in MDD
NCT02473783Phase 2Completed
- Sponsor
- Tri-Service General Hospital
- Start
- Oct 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sertraline in major depressive disorder (MDD), sponsored by Tri-Service General Hospital. Started Oct 2011; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02473783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473783.